SANTÉ INVESTS AT THE LEADING EDGE OF INNOVATION IN HEALTHCARE AND TECHNOLOGY. WE MANAGE OVER A HALF-BILLION DOLLARS OF CAPITAL IN TWO SEPARATE STRATEGIES.
Privately Held Companies
Santé Ventures invests in innovative new healthcare companies, with a particular focus in Biotech, Medtech, and Healthtech.
Publicly Traded Securities
Santé Capital applies state-of-the-art data science and machine learning technologies to generate attractive risk-adjusted returns in a systematic liquid strategy.
02 Santé Ventures Strategy
We search the emerging technology landscape for visionary entrepreneurs and innovative new ideas with the potential to deliver better patient health outcomes through advances in biology, medicine, and information.
03 Santé Capital Strategy
We leverage the latest advances in big data, machine learning, and natural language processing to systematically capture investment opportunities in a liquid portfolio of mispriced publicly traded securities.
04 NewsroomSee All News
Santé Ventures Closes 2020 with New Partner Promotions, Advisory Board…
January 5, 2021
Podcast: Navigating the MedTech Venture Capital Landscape in Austin and…
December 9, 2020
Iterion Therapeutics Secures $17 Million to Advance Development of Tegavivint in Multiple Tumor Settings
February 17, 2021
FARAPULSE Receives European Approval To Commercialize Its Leading Pulsed Field Ablation System To Treat Paroxysmal Atrial Fibrillation
January 29, 2021